Logo image of BX

BLACKSTONE INC (BX) Stock Fundamental Analysis

NYSE:BX - New York Stock Exchange, Inc. - US09260D1072 - Common Stock - Currency: USD

179.39  +1.28 (+0.72%)

Fundamental Rating

5

Overall BX gets a fundamental rating of 5 out of 10. We evaluated BX against 235 industry peers in the Capital Markets industry. BX scores excellent on profitability, but there are concerns on its financial health. BX shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

BX had positive earnings in the past year.
In the past year BX had a positive cash flow from operations.
Each year in the past 5 years BX has been profitable.
BX had a positive operating cash flow in each of the past 5 years.
BX Yearly Net Income VS EBIT VS OCF VS FCFBX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

1.2 Ratios

Looking at the Return On Assets, with a value of 5.62%, BX is in the better half of the industry, outperforming 73.62% of the companies in the same industry.
BX has a better Return On Equity (31.89%) than 95.74% of its industry peers.
BX has a better Return On Invested Capital (16.42%) than 90.64% of its industry peers.
BX had an Average Return On Invested Capital over the past 3 years of 12.81%. This is above the industry average of 7.84%.
The last Return On Invested Capital (16.42%) for BX is above the 3 year average (12.81%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.62%
ROE 31.89%
ROIC 16.42%
ROA(3y)4.65%
ROA(5y)6.43%
ROE(3y)25.68%
ROE(5y)30.98%
ROIC(3y)12.81%
ROIC(5y)17.48%
BX Yearly ROA, ROE, ROICBX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

1.3 Margins

With a Profit Margin value of 19.83%, BX perfoms like the industry average, outperforming 59.57% of the companies in the same industry.
BX's Profit Margin has declined in the last couple of years.
With an excellent Operating Margin value of 49.58%, BX belongs to the best of the industry, outperforming 85.11% of the companies in the same industry.
In the last couple of years the Operating Margin of BX has remained more or less at the same level.
Industry RankSector Rank
OM 49.58%
PM (TTM) 19.83%
GM N/A
OM growth 3Y-4.19%
OM growth 5Y1.25%
PM growth 3Y-6.82%
PM growth 5Y-5.56%
GM growth 3YN/A
GM growth 5YN/A
BX Yearly Profit, Operating, Gross MarginsBX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

3

2. Health

2.1 Basic Checks

The number of shares outstanding for BX has been increased compared to 1 year ago.
BX has more shares outstanding than it did 5 years ago.
BX has a better debt/assets ratio than last year.
BX Yearly Shares OutstandingBX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
BX Yearly Total Debt VS Total AssetsBX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.2 Solvency

An Altman-Z score of 4.14 indicates that BX is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 4.14, BX belongs to the best of the industry, outperforming 81.70% of the companies in the same industry.
BX has a debt to FCF ratio of 3.48. This is a good value and a sign of high solvency as BX would need 3.48 years to pay back of all of its debts.
BX's Debt to FCF ratio of 3.48 is fine compared to the rest of the industry. BX outperforms 74.04% of its industry peers.
A Debt/Equity ratio of 1.56 is on the high side and indicates that BX has dependencies on debt financing.
BX has a worse Debt to Equity ratio (1.56) than 74.47% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.56
Debt/FCF 3.48
Altman-Z 4.14
ROIC/WACCN/A
WACCN/A
BX Yearly LT Debt VS Equity VS FCFBX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

A Current Ratio of 0.71 indicates that BX may have some problems paying its short term obligations.
BX's Current ratio of 0.71 is on the low side compared to the rest of the industry. BX is outperformed by 67.66% of its industry peers.
BX has a Quick Ratio of 0.71. This is a bad value and indicates that BX is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.71, BX is doing worse than 67.23% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.71
Quick Ratio 0.71
BX Yearly Current Assets VS Current LiabilitesBX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 19.95% over the past year.
BX shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 14.97% yearly.
BX shows a strong growth in Revenue. In the last year, the Revenue has grown by 24.23%.
Measured over the past years, BX shows a quite strong growth in Revenue. The Revenue has been growing by 12.51% on average per year.
EPS 1Y (TTM)19.95%
EPS 3Y-0.92%
EPS 5Y14.97%
EPS Q2Q%11.22%
Revenue 1Y (TTM)24.23%
Revenue growth 3Y-16.32%
Revenue growth 5Y12.51%
Sales Q2Q%8.41%

3.2 Future

The Earnings Per Share is expected to grow by 12.53% on average over the next years. This is quite good.
BX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 15.92% yearly.
EPS Next Y7.8%
EPS Next 2Y19.25%
EPS Next 3Y21.34%
EPS Next 5Y12.53%
Revenue Next Year6.57%
Revenue Next 2Y17.15%
Revenue Next 3Y19.3%
Revenue Next 5Y15.92%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BX Yearly Revenue VS EstimatesBX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
BX Yearly EPS VS EstimatesBX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8 10

3

4. Valuation

4.1 Price/Earnings Ratio

BX is valuated quite expensively with a Price/Earnings ratio of 37.77.
74.04% of the companies in the same industry are cheaper than BX, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.35, BX is valued a bit more expensive.
With a Price/Forward Earnings ratio of 27.19, BX can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BX indicates a slightly more expensive valuation: BX is more expensive than 65.53% of the companies listed in the same industry.
BX's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 37.54.
Industry RankSector Rank
PE 37.77
Fwd PE 27.19
BX Price Earnings VS Forward Price EarningsBX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BX is valued a bit cheaper than the industry average as 64.68% of the companies are valued more expensively.
BX's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 60.83
EV/EBITDA 35.19
BX Per share dataBX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BX does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of BX may justify a higher PE ratio.
A more expensive valuation may be justified as BX's earnings are expected to grow with 21.34% in the coming years.
PEG (NY)4.84
PEG (5Y)2.52
EPS Next 2Y19.25%
EPS Next 3Y21.34%

4

5. Dividend

5.1 Amount

BX has a Yearly Dividend Yield of 2.36%.
Compared to an average industry Dividend Yield of 8.05, BX has a dividend in line with its industry peers.
BX's Dividend Yield is comparable with the S&P500 average which is at 2.36.
Industry RankSector Rank
Dividend Yield 2.36%

5.2 History

The dividend of BX is nicely growing with an annual growth rate of 11.16%!
BX has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of BX decreased recently.
Dividend Growth(5Y)11.16%
Div Incr Years1
Div Non Decr Years1
BX Yearly Dividends per shareBX Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

200.72% of the earnings are spent on dividend by BX. This is not a sustainable payout ratio.
The dividend of BX is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP200.72%
EPS Next 2Y19.25%
EPS Next 3Y21.34%
BX Yearly Income VS Free CF VS DividendBX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B
BX Dividend Payout.BX Dividend Payout, showing the Payout Ratio.BX Dividend Payout.PayoutRetained Earnings

BLACKSTONE INC

NYSE:BX (7/25/2025, 11:45:06 AM)

179.39

+1.28 (+0.72%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)07-24 2025-07-24/bmo
Earnings (Next)10-15 2025-10-15/amc
Inst Owners70.96%
Inst Owner Change13.38%
Ins Owners0.83%
Ins Owner Change7.01%
Market Cap217.64B
Analysts75.63
Price Target165.85 (-7.55%)
Short Float %1.76%
Short Ratio3.53
Dividend
Industry RankSector Rank
Dividend Yield 2.36%
Yearly Dividend6.1
Dividend Growth(5Y)11.16%
DP200.72%
Div Incr Years1
Div Non Decr Years1
Ex-Date04-28 2025-04-28 (0.93)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.54%
Min EPS beat(2)0.65%
Max EPS beat(2)12.43%
EPS beat(4)3
Avg EPS beat(4)3.56%
Min EPS beat(4)-5.35%
Max EPS beat(4)12.43%
EPS beat(8)4
Avg EPS beat(8)1.84%
EPS beat(12)7
Avg EPS beat(12)2.31%
EPS beat(16)11
Avg EPS beat(16)8.06%
Revenue beat(2)1
Avg Revenue beat(2)2.32%
Min Revenue beat(2)-0.22%
Max Revenue beat(2)4.86%
Revenue beat(4)1
Avg Revenue beat(4)-0.98%
Min Revenue beat(4)-6.69%
Max Revenue beat(4)4.86%
Revenue beat(8)1
Avg Revenue beat(8)-3.08%
Revenue beat(12)1
Avg Revenue beat(12)-21.14%
Revenue beat(16)5
Avg Revenue beat(16)18.31%
PT rev (1m)7.07%
PT rev (3m)-12.55%
EPS NQ rev (1m)0.28%
EPS NQ rev (3m)-5.35%
EPS NY rev (1m)0.17%
EPS NY rev (3m)-4.78%
Revenue NQ rev (1m)-0.38%
Revenue NQ rev (3m)-2.75%
Revenue NY rev (1m)0.25%
Revenue NY rev (3m)-7.88%
Valuation
Industry RankSector Rank
PE 37.77
Fwd PE 27.19
P/S 16.96
P/FCF 60.83
P/OCF 59.61
P/B 27.28
P/tB 36.69
EV/EBITDA 35.19
EPS(TTM)4.75
EY2.65%
EPS(NY)6.6
Fwd EY3.68%
FCF(TTM)2.95
FCFY1.64%
OCF(TTM)3.01
OCFY1.68%
SpS10.58
BVpS6.58
TBVpS4.89
PEG (NY)4.84
PEG (5Y)2.52
Profitability
Industry RankSector Rank
ROA 5.62%
ROE 31.89%
ROCE 19.68%
ROIC 16.42%
ROICexc 18.35%
ROICexgc 19.92%
OM 49.58%
PM (TTM) 19.83%
GM N/A
FCFM 27.89%
ROA(3y)4.65%
ROA(5y)6.43%
ROE(3y)25.68%
ROE(5y)30.98%
ROIC(3y)12.81%
ROIC(5y)17.48%
ROICexc(3y)14.24%
ROICexc(5y)19.2%
ROICexgc(3y)15.53%
ROICexgc(5y)21.12%
ROCE(3y)15.37%
ROCE(5y)21.01%
ROICexcg growth 3Y-21.19%
ROICexcg growth 5Y9.44%
ROICexc growth 3Y-21.05%
ROICexc growth 5Y9.86%
OM growth 3Y-4.19%
OM growth 5Y1.25%
PM growth 3Y-6.82%
PM growth 5Y-5.56%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 1.56
Debt/FCF 3.48
Debt/EBITDA 1.95
Cap/Depr 202.82%
Cap/Sales 0.57%
Interest Coverage 14.9
Cash Conversion 57.07%
Profit Quality 140.65%
Current Ratio 0.71
Quick Ratio 0.71
Altman-Z 4.14
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)360.42%
Cap/Depr(5y)264.86%
Cap/Sales(3y)2.01%
Cap/Sales(5y)1.63%
Profit Quality(3y)249.28%
Profit Quality(5y)197.86%
High Growth Momentum
Growth
EPS 1Y (TTM)19.95%
EPS 3Y-0.92%
EPS 5Y14.97%
EPS Q2Q%11.22%
EPS Next Y7.8%
EPS Next 2Y19.25%
EPS Next 3Y21.34%
EPS Next 5Y12.53%
Revenue 1Y (TTM)24.23%
Revenue growth 3Y-16.32%
Revenue growth 5Y12.51%
Sales Q2Q%8.41%
Revenue Next Year6.57%
Revenue Next 2Y17.15%
Revenue Next 3Y19.3%
Revenue Next 5Y15.92%
EBIT growth 1Y22.76%
EBIT growth 3Y-19.82%
EBIT growth 5Y13.91%
EBIT Next Year5.28%
EBIT Next 3Y18.21%
EBIT Next 5Y6.22%
FCF growth 1Y-3.07%
FCF growth 3Y-4.46%
FCF growth 5Y12.44%
OCF growth 1Y-7.35%
OCF growth 3Y-4.41%
OCF growth 5Y12.14%